**Specifications Table**TableSubject area*Biology*More specific subject area*Molecular biology*Type of data*Text, excel file, table*How data was acquired*Affymetrix Human Genome HG U133 Plus 2.0 array*Data formatRaw, processedExperimental factors*miR-93 was over-expressed in Jurkat cells by transduction with a lentiviral transgenic construct encoding for miR-93 under a PGK promoter. A cognate vector encoding for a control hairpin was used to generate control cell line.*Experimental features*We analyzed the whole-transcript expression profiling of Jurkat cells (T-ALL cell line) over-expressing miR-93 using a microarray experiment.*Data source location*University of Rome, "La Sapienza", Rome, Italy*Data accessibilityData is within this article and microarray data are available through Array Express repository (Accession Number ArrayExpress: E-MTAB-4588)

**Value of the data**•A global gene expression analysis of human Jurkat cells (T-ALL cell line) over-expressing miR-93.•miR-93 is frequently dysregulated in several human malignancies. This dataset can represent a further insight into gene expression changes and GO Terms associated with miR-93 over-expression.•These data can represent a benchmark for further experiments in order to clarify the meaning of the biological processes identified by the in silico data analysis.

1. Data {#s0005}
=======

The Affymetrix mRNA profile data are provided as.CEL files deposited on Array Express (<http://www.ebi.ac.uk/arrayexpress/arrays/E-MTAB-4588>). RNA was extracted from miR-93 over-expressing Jurkat cells (pRRL-93) and matched control cell line (pRRL-Ctrl). Three biological replicates have been performed. Data have been normalized and processed as described in the following section. The attached excel file ([miR93_all_filtered_genes.xls](#s0050){ref-type="sec"}) represents the filtered datasest with relative adjusted *p*-values.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cell and culture conditions {#s0015}
--------------------------------

Jurkat cells were purchased from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) and cultured in RPMI-1640 Medium (SIGMA) supplemented with 10% fetal bovine serum (SIGMA), at 37 °C in a 5% CO~2~ atmosphere.

2.2. Construction of a lentiviral vector expressing miR-93 {#s0020}
----------------------------------------------------------

PGK-miR93 expression construct was obtained amplifying a region of about 200 nt containing miR-93 precursor, from human genomic DNA. We used the following primers designed to incorporate RsrII and XbaI restriction sites and 6 bp of extra random sequence to aid in restriction digestion: 5′CGCGCGCGGACCGCCCACTTCTTAACCTTC-3′ (forward), 5′GCGCGCTCTAGAGAGTTCAGCTGTCCTGTG-3′ (reverse). The amplified region was cloned into the RsrII NheI sites of \#1074.1071.hPGK.GFP.WPRE.mhCMV.dNGFR.SV40PA (kindly provided by Prof Luigi Naldini). PGK-control was obtained by substituting miR-93 precursor fragment (RsrI--NheI) with a sequence encoding for an hairpin yielding a 22-mer RNA designed to lack homology to any human gene. The lentiviral vector expressing miR-93 and the packing vectors pLP1, pLP2, and pLP/VSVG were co-transfected into HEK293T cells, and culture medium was collected at 48 h. The medium was filtered through 0.45-μm pore nitrocellulose filters and then centrifuged in a Beckman ultracentrifuge (Beckman, OptimaTM LE-80K) at 25,000 rpm for 2 h at 4 °C. The precipitate was re-suspended in RPMI complete medium. The viral supernatant and Polybrene 8 μg/ml were added to the Jurkat cells.

2.3. mRNA microarray data normalization and processing {#s0025}
------------------------------------------------------

Three biological replicates for each sample were hybridized on the array *Human 2.0 ST microarrays*, Affymetrix, Santa Clara, CA. Affymetrix.

CEL files were separately processed for each replicate and experimental condition using the Robust Multi-array Average (RMA) procedure with quantile normalization, log2 transformation and background subtraction, as implemented in the *rma* function from R/BioConductor [@bib1] package *oligo*.

Before calling the differentially expressed genes (DEGs), gene probes were filtered to remove (a) nonspecific probes and probes lacking a reference ID in public information repositories; (b) probes showing minimal variation across samples; and (c) probes with constant low expression across samples.

Particularly, as supplied in the R/BioConductor [@bib1] package *genefilter*, the function *nsFilter* was applied to the normalized expression values with default arguments in order to:(1)remove Affymetrix control probe sets and features without an Entrez Gene ID annotation; and(2)probe sets were required to have interquartile range (IQR) of their log2-transformed values at least equal to 0.5;

Moreover, the function *kOverA* from the package *genefilter* was applied in order to remove probe sets marked by low or null expression in total RNA samples (i.e.: require expression value \>log 2(100) in both miR-93 over-expressing samples and control samples).

Therefore, we ended up with a list of 6559 filtered probe sets. The *limma* package from R/BioConductor [@bib1] open source software for bioinformatics was used to calculate moderated *t*-statistics (based on the empirical Bayes approach) to identify DEGs between the miR-93 over-expressing group and control group.

Because of multiple hypothesis testing, *p*-values were adjusted by the false discovery rate (FDR) method ([miR93_all_filtered_genes.xls](#s0050){ref-type="sec"}).

2.4. GO terms analysis {#s0030}
----------------------

Basing on the log2 Fold Change values, a ranked list of negatively regulated genes was produced. This list has been submitted into the GOrilla software tool [@bib2] as single ranked list of genes (miR93.negative.ranked.list.txt) setting a *p*-value cutoff of 10E-6 ([Table1_GOTERMS_Negative_ranked_list.png](#s0050){ref-type="sec"}).
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